|
Title
|
Published
|
Price
|
|
Cardiovascular Outlook: Pharmaceutical, Medical Device, New Technologies - Past, Present, and Future
By: Canon Communications, LLC
Cardiovascular disease is the leading cause of death in the United States, affecting an estimated 80.7 million American adults, with estimated treatment costs of more than $313.8 billion annually. This report contains qualitative analysis of
|
more...
|
10/1/2009
|
$535.00
|
|
Cardiovascular and Circulatory System Hypertension Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Hypertension Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of hypertension drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Hypercholesterolemia Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Hypercholesterolemia Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of hypercholesterolemia drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Edema Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Edema Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of edema drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Congestive Heart Failure Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Congestive Heart Failure Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of congestive heart failure drugs by company and by
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Atrial Fibrillation Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Atrial Fibrillation Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of atrial fibrillation drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Atherosclerosis or Coronary Artery Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of atherosclerosis or coronary artery disease drugs
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Angina Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Angina Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of angina drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Acute Coronary Syndromes Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Acute Coronary Syndromes Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of acute coronary syndromes drugs by company and by
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Varicose Veins Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Varicose Veins Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of varicose veins drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Thrombosis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Thrombosis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of thrombosis drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Stroke Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Stroke_Cardiovascular and Circulatory System Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of stroke_cardiovascular and circulatory system drugs by company
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Restenosis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Restenosis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of restenosis drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Peripheral Vascular Disease Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Peripheral Vascular Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of peripheral vascular disease drugs by company and by
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Myocardial Infarction Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Myocardial Infarction Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of myocardial infarction drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Ischemia Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Ischemia Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of ischemia drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cardiovascular and Circulatory System Intermittent Claudication Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Intermittent Claudication Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of intermittent claudication drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Biomarkers- Advanced Technologies and Global Market (2009-2014)
By: MarketsandMarkets
Report Description
The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and
|
more...
Buy by the section | Search inside this report
|
9/9/2009
|
$4,650.00
|
|
Disease and Therapy Review: Heart Failure
By: Timely Data Resources, Inc.
The Heart Failure Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of
|
more...
Search inside this report
|
9/1/2009
|
$750.00
|
|
Emerging Opportunities in Controlled-Release Generic Drugs
By: Espicom Healthcare Intelligence
This new report identifies 30 controlled-release drugs valued at US$15 billion, many of which will be losing patent protection in the medium
|
more...
Search inside this report
|
8/21/2009
|
$1,890.00
|
|
Where Next for Thrombosis?
By: mediKOL Ltd.
The thrombosis market is poised to change dramatically. A number of hotly anticipated new oral therapies are set to enter the market with the potential to radically change the landscape. But how will
|
more...
Search inside this report
|
8/1/2009
|
$13,500.00
|
|
Pacemakers Pipeline, Technology and Market Forecasts to 2015
By: GlobalData
Pacemakers Pipeline, Technology and Market Forecasts to 2015
Summary
GlobalData’s medical device report: “Pacemakers Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global
|
more...
Search inside this report
|
7/14/2009
|
$2,000.00
|
|
Research Report On Treatment Drug Of Cerebrovascular Disease
By: SunFAITH China Ltd.
Cerebrovascular disease is one of the three fatal diseases in our country; urban cerebrovascular disease ranks the second in the causes of death, second only to malignant tumor. With people’s growing awareness and knowledge of
|
more...
|
7/13/2009
|
$400.00
|
|
Global Cardiovascular Drugs Market 2009-2024
By: Visiongain
Cardiovascular disorders are leading causes of death worldwide. Cardiovascular therapeutics form a central part of the global pharmaceutical market, with a wide range of treatments, including leading blockbusters. As the patient population grows and cardiovascular
|
more...
|
6/30/2009
|
$2,502.00
|
|
Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015
By: GlobalData
Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015 Summary GlobalData’s “Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015” report is an essential source of data and analysis on the
|
more...
|
6/11/2009
|
$3,500.00
|
|
Title
|
Published
|
Price
|
(0 items)
